Literature DB >> 14677763

Induction of apoptosis by EGCG in selected tumour cell lines in vitro.

Sylwia Borska1, Elzbieta Gebarowska, Teresa Wysocka, Małgorzata Drag-Zalesińska, Maciej Zabel.   

Abstract

One of the best recognised polyphenols of plant origin, epigallocatechin-3-gallate (EGCG) is contained mainly in green tea and in grapes. Studies performed in vivo and in vitro have demonstrated high probability of anti-neoplastic potential of the compound, due to its capacity to induce programmed cell death. The present studies were aimed at evaluation of apoptosis induction in cells of three selected tumour cell lines, subjected to action of various concentrations of EGCG. The experiment was performed on cultures of HEp-2 laryngeal carcinoma cells, LoVo colon carcinoma cells, HeLa cervical carcinoma cells and on normal myoepithelial cell line, HS. EGCG was found to induce apoptosis in cells of the examined neoplastic lines in a dose-related manner. Moreover, effect of EGCG on normal cells of HS line was found to be much less pronounced as compared to effects exerted on sensitive neoplastic cells.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 14677763

Source DB:  PubMed          Journal:  Folia Histochem Cytobiol        ISSN: 0239-8508            Impact factor:   1.698


  8 in total

1.  Specific killing of multiple myeloma cells by (-)-epigallocatechin-3-gallate extracted from green tea: biologic activity and therapeutic implications.

Authors:  Masood A Shammas; Paola Neri; Hemanta Koley; Ramesh B Batchu; Robert C Bertheau; Vidit Munshi; Rao Prabhala; Mariateresa Fulciniti; Yu Tzu Tai; Steven P Treon; Raj K Goyal; Kenneth C Anderson; Nikhil C Munshi
Journal:  Blood       Date:  2006-06-29       Impact factor: 22.113

2.  The dietary bioflavonoid quercetin synergizes with epigallocathechin gallate (EGCG) to inhibit prostate cancer stem cell characteristics, invasion, migration and epithelial-mesenchymal transition.

Authors:  Su-Ni Tang; Chandan Singh; Dara Nall; Daniel Meeker; Sharmila Shankar; Rakesh K Srivastava
Journal:  J Mol Signal       Date:  2010-08-18

3.  Epigallocatechin-3-gallate (EGCG) inhibits the migratory behavior of tumor bronchial epithelial cells.

Authors:  Salma Hazgui; Arnaud Bonnomet; Béatrice Nawrocki-Raby; Magali Milliot; Christine Terryn; Jérôme Cutrona; Myriam Polette; Philippe Birembaut; Jean-Marie Zahm
Journal:  Respir Res       Date:  2008-04-21

4.  Synergistic effect of curcumin on epigallocatechin gallate-induced anticancer action in PC3 prostate cancer cells.

Authors:  Dae-Woon Eom; Ji Hwan Lee; Young-Joo Kim; Gwi Seo Hwang; Su-Nam Kim; Jin Ho Kwak; Gab Jin Cheon; Ki Hyun Kim; Hyuk-Jai Jang; Jungyeob Ham; Ki Sung Kang; Noriko Yamabe
Journal:  BMB Rep       Date:  2015-08       Impact factor: 4.778

5.  Epigallocatechin gallate inhibits the growth and promotes the apoptosis of bladder cancer cells.

Authors:  Chenchen Feng; Yatfaat Ho; Chuanyu Sun; Guowei Xia; Qiang Ding; Bin Gu
Journal:  Exp Ther Med       Date:  2017-08-21       Impact factor: 2.447

Review 6.  Potential Therapeutic Targets of Epigallocatechin Gallate (EGCG), the Most Abundant Catechin in Green Tea, and Its Role in the Therapy of Various Types of Cancer.

Authors:  Saleh A Almatroodi; Ahmad Almatroudi; Amjad Ali Khan; Fahad A Alhumaydhi; Mohammed A Alsahli; Arshad Husain Rahmani
Journal:  Molecules       Date:  2020-07-09       Impact factor: 4.411

7.  (-)-Epigallocatechin-3-gallate encapsulated realgar nanoparticles exhibit enhanced anticancer therapeutic efficacy against acute promyelocytic leukemia.

Authors:  Wei Fang; Zhao Liang Peng; Ya Ji Dai; Dian Lei Wang; Peng Huang; He Ping Huang
Journal:  Drug Deliv       Date:  2019-12       Impact factor: 6.419

8.  (-)-Epigallocatechin-3-gallate Modulates the Differential Expression of Survivin Splice Variants and Protects Spermatogenesis During Testicular Torsion.

Authors:  Nada Al-Ajmi; May Al-Maghrebi; Waleed Mohammed Renno
Journal:  Korean J Physiol Pharmacol       Date:  2013-07-30       Impact factor: 2.016

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.